These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35296341)
1. Erucin inhibits osteoclast formation via suppressing cell-cell fusion molecule DC-STAMP without influencing mineralization by osteoblasts. Takagi T; Inoue H; Fujii S; Takahashi N; Uehara M BMC Res Notes; 2022 Mar; 15(1):105. PubMed ID: 35296341 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphane inhibits osteoclast differentiation by suppressing the cell-cell fusion molecules DC-STAMP and OC-STAMP. Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M Biochem Biophys Res Commun; 2017 Jan; 483(1):718-724. PubMed ID: 27979663 [TBL] [Abstract][Full Text] [Related]
3. Regulators of osteoclast differentiation and cell-cell fusion. Miyamoto T Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633 [TBL] [Abstract][Full Text] [Related]
4. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity. Miyamoto T Mod Rheumatol; 2006; 16(6):341-2. PubMed ID: 17164993 [TBL] [Abstract][Full Text] [Related]
5. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice. Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2. Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M Biosci Biotechnol Biochem; 2017 Jun; 81(6):1220-1223. PubMed ID: 28136694 [TBL] [Abstract][Full Text] [Related]
7. Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression. Kim HJ; Hong J; Jung JW; Kim TH; Kim JA; Kim YH; Kim SY Int Immunopharmacol; 2010 Nov; 10(11):1440-7. PubMed ID: 20831919 [TBL] [Abstract][Full Text] [Related]
8. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption. Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142 [TBL] [Abstract][Full Text] [Related]
9. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells. Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096 [TBL] [Abstract][Full Text] [Related]
10. Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology. Witwicka H; Hwang SY; Reyes-Gutierrez P; Jia H; Odgren PE; Donahue LR; Birnbaum MJ; Odgren PR PLoS One; 2015; 10(6):e0128275. PubMed ID: 26042409 [TBL] [Abstract][Full Text] [Related]
11. Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway. Kim HJ; Seong HS; Choi Y; Heo SC; Kim YD Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182361 [TBL] [Abstract][Full Text] [Related]
12. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. Yang M; Birnbaum MJ; MacKay CA; Mason-Savas A; Thompson B; Odgren PR J Cell Physiol; 2008 May; 215(2):497-505. PubMed ID: 18064667 [TBL] [Abstract][Full Text] [Related]
13. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Kim K; Lee SH; Ha Kim J; Choi Y; Kim N Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208 [TBL] [Abstract][Full Text] [Related]
14. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9. Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736 [TBL] [Abstract][Full Text] [Related]
15. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724 [TBL] [Abstract][Full Text] [Related]
16. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens. Mensah KA; Ritchlin CT; Schwarz EM J Cell Physiol; 2010 Apr; 223(1):76-83. PubMed ID: 20039274 [TBL] [Abstract][Full Text] [Related]
17. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628 [TBL] [Abstract][Full Text] [Related]
18. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521 [TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts. Zeng Z; Zhang C; Chen J J Bone Miner Metab; 2013 Jul; 31(4):409-16. PubMed ID: 23525827 [TBL] [Abstract][Full Text] [Related]
20. Propofol promotes osteoclastic bone resorption by increasing DC-STAMP expression. Kim EJ; Kim HJ; Baik SW; Kim KH; Ryu SJ; Kim CH; Shin SW J Dent Anesth Pain Med; 2018 Dec; 18(6):349-359. PubMed ID: 30637345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]